ABSTRACT This study in Alexandria, Egypt was conducted to investigate the distribution of different hepatitis B virus (HBV) markers in apparently healthy blood donors who were hepatitis B surface antigen (HBsAg) negative, and to determine the major independent risk factors. Evidence of past exposure to HBV was found in 148/508 screened donors (29.1%). The most prevalent marker was anti-HBc in 124/508 donors (24.4%), half of whom (63/124) showed anti-HBc only. Anti-HBs prevalence was 15.9%, combined anti-HBc and antiHBs was 12.0% and anti-HBe was 5.7%. Independent risk factors associated with the presence of at least 1 marker were: being married (OR 3.82), history of blood transfusion (OR 3.04) and parenteral antibilharzial treatment (OR 2.49). Receiving a full HBV vaccination schedule was reported by 39 donors, but only 1 of them had isolated anti-HBs. The relatively high prevalence of HBV exposure necessitates solid infection control measures and adult vaccination programme awareness. 
Serological pattern of hepatitis B virus among HBsAg negative blood donors in Alexandria, Egypt Introduction
Hepatitis B virus (HBV) infection is a serious global health problem, with 2 billion people infected worldwide, and 400 million suffering from chronic HBV infection. Approximately 2 people die each minute from HBV infection; representing the 10th leading cause of death worldwide [1] . Although the prevalence of HBV has declined due to the effectiveness of vaccination programmes, HBV infection is still a significant health concern in the world [2] . The prevalence of HBV infection in Egypt showed a massive decline after the application of the vaccination programme in 1991, from 10.1% in 1985 [3] to 1.3% in a recent study in 2009 on blood donors [4] .
The presence of hepatitis B virus surface antigen (HBsAg) is an essential serological marker for diagnosing ongoing HBV infection; however, the presence of IgG antibodies against core antigen (anti-HBc), alone or in combination with antibodies against surface antigen (anti-HBs), indicates previous exposure to the virus [5] . Absence of HBsAg can be interpreted in a number of ways: no current or past HBV infection if no other HBV markers are detected; recovered past infection with detectable anti-HBs and anti-HBc; immunity due to vaccination with only detectable isolated anti-HBs; occult HBV infection in the presence of HBV-DNA in serum or liver with or without other markers; or false occult HBV infection if the serum DNA is comparable to that of overt infection in case of HBsAg mutants [6] [7] [8] . The persistent presence of antiHBc is associated with chronic HBV infection and can be selective for HBVinfected samples even in the absence of HBsAg [9] . These patients who remain HBsAg negative/anti-HBc-positive are at risk of transmitting the disease on rare occasions, such as donation of solid organ tissue, or of reactivation of HBV disease if they are immunosuppressed [10] .
Screening for HBV status using these markers provides an overview of the exposure, probability of transmission and immune status of the general population. This is crucial to anticipating the future impact of the disease on the health system and also to ensure adequate allocation of financial resources. We therefore conducted this study to investigate the distribution of anti-HBc and other HBV markers in apparently healthy blood donors who were HBsAg negative and to determine the major independent risk factors beyond HBV exposure with the goal of improving blood donation safety.
Methods

Sample
The study population (n = 508) was randomly selected from among Egyptian donors from blood banks in Alexandria. Assuming a 50% prevalence of anti-HBc among blood donors, the minimum required sample size was estimated by Epi Info, version 6 to be 474 blood donors with a precision = 4.5%, an α-level = 0.05 and a power = 80%. The researchers visited the blood banks at least 4 times weekly for a period of at least 4 hours. All donors attending blood banks during the researchers' visits and who consented to participate were included. Blood bank laboratory results were collected thereafter and only the eligible donors were included. The donors were screened continuously and the results from the blood banks were obtained a week later and those who had positive HBsAg were excluded (n = 13). There were 73 people who refused to participate.
Data collection
The study was conducted from September 2009 to March 2011. An interview using a structured questionnaire was conducted at the time of the participant's blood donation after getting his/her informed consent. The questionnaire included information about demographic, social and behavioural factors. Blood samples were taken from each participant and sera were stored at -20 °C until tested. After obtaining the blood bank results, HBsAg reactive sera were excluded and the final number of participants included in the study was 508 HBsAg non-reactive blood donors.
Serology comprised anti-HBc, antiHBs, hepatitis B e antigen (HBeAg) antibodies against HBeAg (anti-HBe) and IgM antibody to hepatitis B core antigen (anti-HBc IgM). Every test was performed twice using enzyme-linked immunosorbent assay (Dialab GmbH) in accordance with the manufacturer's instructions.
The study protocol was approved by the research ethics committee of the High Institute of Public Health, University of Alexandria.
Data entry and analyses
Data entry and analyses were performed using SPSS software, version 15 .0. The prevalence of each HBV serological marker was calculated as a percentage of the total population included in the study. The confidence intervals (CI) were calculated manually at the 95% level with continuity correlation. The blood donor was considered exposed if at least 1 positive marker was detected. The titres of different markers in serum were categorized according to quarter percentiles. Cut-off values for low titres were < 50th percentile and for high titres were ≥ 50th percentile. The association between the demographic and social variables and the prevalence of HBV markers was evaluated using the chi-squared test. Multivariate logistic regression analyses were done to reveal the independent predictors of past exposure with or without immunity. A 2-sided P-value < 0.05 was considered statistically significant.
Results
The total number of people with evidence of exposure to HBV infection among the study group (i.e. presence of at least 1 serologic marker) was 148/508, a prevalence of 29.1%. They will be referred to as the exposed group. The prevalence of each marker is shown in Table 1 . The most frequent marker was anti-HBc (24.4%), followed by anti-HBs (15.9%) and anti-HBe (5.7%). The number of individuals who had combined anti-HBs and anti-HBc was 61 (12.0%), making the anti-HBc alone (without anti-HBs) 50.8% (63/124) of the total positive anti-HBc. The majority of anti-HBs seropositive donors (n = 49; 60.5%) had high titres compared with almost half of the anti-HBc positive sera (n = 61; 49.2%). Anti-HBc IgM and HBeAg were detected in 3 (0.6%) and 2 (0.4%) individuals respectively; all of them had borderline cut-off levels.
As shown in Table 2 , although most of the exposed group were males (114/148), female sex was significantly associated with exposure (P = 0.006). The mean age of the exposed group was 38.9 (SD 9.9) years, with 44.2% being older than 35 years. The exposed donors were significantly older than the unexposed group (P < 0.001). Marriage and rural residence were significantly associated with exposure (83.1% and 41.9% versus 61.9% and 31.1% in the exposed and unexposed groups respectively) (P < 0.001, P = 0.02 respectively). Neither education level nor type of work showed any association with the presence of HBV markers. Other factors that showed significance in the univariate analysis (Table 3) were: history of circumcision using traditional practices (P = 0.047), travelling to HBV-endemic area (P = 0.008), a history of frequent blood transfusion, even after 1992 (when screening began in blood banks) (P = 0.01), frequent dental manipulation (P = 0.002), history of jaundice (P = 0.009), reporting elevated liver enzymes (P = 0.04) and receiving schistosomiasis treatment by injection (P < 0.001). The independent risk factors revealed in the logistic regression analysis are shown in Table 4 .
Among all participants, 461 (90.7%) gave no history of receiving HBV vaccine. No significant relation was found between seropositivity with isolated anti-HBs and self-reported history of receiving HBV vaccine (Table 5) . Of the 37 who reported history of complete HBV vaccination, none had HBeAg, 1 had anti-HBc IgM, 4 (10.8%) showed anti-HBe and 9 (24.3%) were anti-HBcpositive. Surprisingly, 8/37 (21.6%) of them showed anti-HBs, of whom 1/37 showed only anti-HBs. Most of the blood donors showing anti-HBs alone (16 out of 18; 88.9%) did not report any history of vaccination.
Discussion
The assumed rarity of hepatitis transmission by blood transfusion has been attributed to the screening of blood for markers of HBV and HCV, which has been universally applied in blood banks worldwide since 1992. However, the univariate analysis of different risk factors for hepatitis infection in the present study documented that positive history of frequent blood transfusion especially after 1992 was a significant risk factor for evidence of HBV exposure. Meanwhile, the logistic regression analysis showed that history of blood transfusion was one of the independent risk factors for HBV infection. This latter finding matches well with other published data [11] . It has been reported that despite continued improvements in the selection criteria of blood bank donors and of the applied serological tests protocol in sample evaluation, the transmission of HBV infection by blood transfusion still occurs in a proportion of cases even if the transfused blood tested negative for HBsAg using highly sensitive assays [12] .
The most prevalent marker among exposed people in this study was antiHBc (24.4%). It should be noted that false positivity is unlikely in the present work as the test was double-checked and was considered positive only if both assays clearly indicated that. Anti-HBc is the first antibody to appear following acute HBV infection and persists at high levels following resolution of infection [13] . It is a marker of acute, chronic or resolved infection and remains detectable for life [14] . The reported prevalence of anti-HBc markers among donors at blood banks varies in other published studies depending on the local prevalence of HBV, ranging from 0.4% in low-endemic areas to 70% in high-endemic areas [11, [15] [16] [17] .
As the safety of blood products is one of the major issues in the area of transfusion medicine, the combined strategy of testing for both HBsAg and anti-HBc is practised worldwide and testing for anti-HBc was adopted in some areas in the world. This strategy has been found to markedly minimize the possibility of HBV transmission via blood transfusion [14] . On the other hand, it may lead to the exclusion of a significant number of donors' blood, as reported in Brazil where high levels of anti-HBc were recorded (up to 57%) [18] . There has recently been concern about "anti-HBc only" or isolated antiHBc individuals, i.e. those in whom antiHBc is the only detectable HBV marker with no evidence of HBsAg or anti-HBs [19] . A serological pattern of anti-HBc as a sole marker is not infrequent. It was reported that 3.7% of randomly selected Lebanese blood donors were confirmed as isolated anti-HBc [20] . Similarly, isolated anti-HBc was reported in 125 out of 6035 (2.1%) of Saudi blood donors [21] . Another study performed on 545 Iranian blood donors; 8% of them were positive for isolated anti-HBc [22] . The results of the present study further confirmed the high rate of isolated anti-HBc among tested blood donors 63/508 (12.4%).
Besides false positive results of anti-HBc assays [23] , emergence of 's' mutants which could occur during therapy with nucleoside inhibitors was also suggested as a possible explanation for the presence of isolated anti-HBc [24] . It was declared that mutations occur in HBsAg making it undetectable by conventional assays [25] . Alhababi et al. suggested that in communities where the circulation of antigenic determinant mutants are increasing, surveillance of isolated anti-HBc cases may be a valuable tool to identify the mutants [26] . Some authors considered anti-HBc alone as evidence of past infection with HBV when the anti-HBs level has fallen below the detection level [20] . Others concluded that many years after chronic carriage the level of HBsAg in the circulation becomes too low to be detected [16] . Finally, anti-HBc alone has also been attributed to an acute HBV infection during the so-called "window period" between the disappearance of HBsAg and the appearance of HBsAb. In this case, if the individual is followed up, anti-HBs will appear [13] .
In the present study, combined anti-HBc and anti-HBs was present in almost half of those showing anti-HBc (61/124), constituting 12.0% of the total population tested for HBV markers. A similar high frequency was found by Aguiar et al. [18] . These cases were considered to be previously infected and to have become immune to HBV infection, although we need to bear in mind that the degree of protection depends on the level of anti-HBs. Kaminski et al. reported that 22 out of 41 donors with evidence of anti-HBc had anti-HBs level > 100 mIU/mL, a level generally considered protective against HBV infection [11] . Other investigators stressed the fact that blood components positive for anti-HBc and anti-HBs do not appear to transmit HBV and there is clearly an inverse correlation between anti-HBs level and infectivity [27] . The above explanations could be applied to the combined anti-HBc and anti-HBs cases found in this study, as we also found that a high proportion of anti-HBs subjects (60.5%) had high titres.
Older age was significantly associated with the detection of HBV markers. Similarly, Dettori et al. reported that the prevalence of markers of a previous HBV infection was low in young persons, whereas in those aged > 50 years the prevalence of markers of previous HBV infection was high [28] . Other authors also showed that anti-HBc prevalence increased with age, suggesting that sexual activity may contribute to horizontal transmission of this infection among adults [29] . This latter explanation finds support in the present work, as being married was a significant risk factor for HBV infection [30] . The significant association of HBV markers with older age could also be due to the greater number of years of potential exposure, lack of awareness of HBV infection and lack of awareness and eventually infrequent HBV vaccination in adults. The latter finding was supported in the present study as 90.7% of our total sample did not report any Although several published studies concluded that male sex seemed to play an important role in acquisition of HBV infection [29, 31, 32] , the results of the present study revealed that females were more prevalent among the exposed group compared with the unexposed group (23.0% and 13.1%).
The other risk factors revealed in this study, namely circumcision in traditional facilities, rural residence and receiving parenteral schistosomiasis treatment denote a lack of hygiene and poor infection control practices in circumcisions and injections. Similar conclusions were reported by other authors who documented community delivery with traditional birth attendants as an important route of horizontal spread of HBV. They suggested that this may be attributed to the procedure being practised under poor hygiene conditions with sharing of ancillary supply equipment such as scissors [33] . This was further documented in another study, which revealed that the main risk factors for HBV transmission was syringe exchange, sexual exposure, nosocomial exposure and more rarely blood transfusion [28] .
Conclusion
The prevalence of exposure to HBV infection in this study in Egypt was higher than expected. Public health measures should be adopted for HBV control including proper infection control measures and better awareness and evaluation of adult vaccination programmes. The need for screening of HBsAg negative donated blood for anti-HBc needs to be evaluated.
